.Atea Pharmaceuticals' antiviral has failed yet another COVID-19 test, yet the biotech still keeps o...
.Neurocrine Biosciences' mental illness program pivot has actually fallen short. The biotech was una...
.Sanofi has actually made a late entry to the radioligand gathering, spending 100 million europeans ...
.After F2G's very first attempt to obtain a new class of antifungal to market was actually wrecked d...
.Moderna has actually pledged to cut R&D costs by $1.1 billion by 2027. The choice to shrink the ...
.Just 4 months after Sanofi bet $80 thousand in ahead of time cash money on Pivot Rehabs' losmapimod...
.Cancer firm Oncternal Rehabs is actually folding all its own medical tests and also giving up staff...
.Roche is actually keeping out chances that its injectable weight problems prospect can ultimately i...
.Novo Nordisk has actually raised the lid on a phase 1 test of its oral amylin and also GLP-1 recept...
.Merely a couple of short full weeks after winning an FDA Fast lane tag for its investigational BTK ...